0407 ACT-541468, A Dual Orexin Receptor Antagonist, For The Treatment Of Insomnia Disorder: A Randomized, Double-Blind, Placebo-Controlled, 5-Period, 5-Treatment Crossover Dose-Response Phase 2 Study In The Elderly

Article de revue

Avec comité de lecture

Gary Zammit, Yves Dauvilliers, Scott Pain, Dalma Seboek Kinter et Dieter Kunz

Sleep (New York, N.Y.), Vol.42(Supplement_1), pp.A165-A165

13/04/2019

Indicateurs

1 Consultations de la notice

Titre: 0407 ACT-541468, A Dual Orexin Receptor Antagonist, For The Treatment Of Insomnia Disorder: A Randomized, Double-Blind, Placebo-Controlled, 5-Period, 5-Treatment Crossover Dose-Response Phase 2 Study In The Elderly
Créateurs - sans rôle: Gary Zammit - Clinilabs
Yves Dauvilliers - Sleep and Wake Disorders Centre, Department of Neurology, Gui de Chauliac Hospital, Montpellier cedex, France
Scott Pain - Idorsia Pharmaceuticals Ltd
Dalma Seboek Kinter - Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland
Dieter Kunz - Intellux GmbH, Berlin, Germany
Détails de publication: Sleep (New York, N.Y.), Vol.42(Supplement_1), pp.A165-A165
Identifiants: 99139935609311
Unité académique: Institut des Neurosciences de Montpellier - INM
Langue: English
Type de ressource: Journal article